Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 258

1.

Paradoxical Pustular Psoriasis in a Patient With Psoriatic Arthritis on Secukinumab Treatment.

Abbruzzese A, Venerito V, Lopalco G, Fornaro M, Giannotta M, Iannone F.

J Clin Rheumatol. 2019 Jun 11. doi: 10.1097/RHU.0000000000001076. [Epub ahead of print] No abstract available.

PMID:
31192857
2.

Expression patterns and functional evaluation of RGMa during the early phase of peripheral nerve regeneration using the mouse median nerve model.

Jaminet P, Schäufele M, Mager A, Fornaro M, Ronchi G, Geuna S, Schaller HE, Rosenberger P, Köhler D.

Restor Neurol Neurosci. 2019;37(3):265-272. doi: 10.3233/RNN-190913.

PMID:
31177252
3.

Influence of changes in cholesterol levels and disease activity on the 10 years cardiovascular risk estimated with different algorithms in rheumatoid arthritis patients.

Fornaro M, Cacciapaglia F, Venerito V, Lopalco G, Iannone F.

Ann Rheum Dis. 2019 May 29. pii: annrheumdis-2019-215715. doi: 10.1136/annrheumdis-2019-215715. [Epub ahead of print] No abstract available.

PMID:
31142479
4.

The FDA "Black Box" Warning on Antidepressant Suicide Risk in Young Adults: More Harm Than Benefits?

Fornaro M, Anastasia A, Valchera A, Carano A, Orsolini L, Vellante F, Rapini G, Olivieri L, Di Natale S, Perna G, Martinotti G, Di Giannantonio M, De Berardis D.

Front Psychiatry. 2019 May 3;10:294. doi: 10.3389/fpsyt.2019.00294. eCollection 2019.

5.

Treatment-Resistant to Antipsychotics: A Resistance to Everything? Psychotherapy in Treatment-Resistant Schizophrenia and Nonaffective Psychosis: A 25-Year Systematic Review and Exploratory Meta-Analysis.

Polese D, Fornaro M, Palermo M, De Luca V, de Bartolomeis A.

Front Psychiatry. 2019 Apr 17;10:210. doi: 10.3389/fpsyt.2019.00210. eCollection 2019.

6.

Unveiling the Efficacy, Safety, and Tolerability of Anti-Interleukin-1 Treatment in Monogenic and Multifactorial Autoinflammatory Diseases.

Bettiol A, Lopalco G, Emmi G, Cantarini L, Urban ML, Vitale A, Denora N, Lopalco A, Cutrignelli A, Lopedota A, Venerito V, Fornaro M, Vannacci A, Rigante D, Cimaz R, Iannone F.

Int J Mol Sci. 2019 Apr 17;20(8). pii: E1898. doi: 10.3390/ijms20081898. Review.

7.

The Relationship between Dietary Vitamin K and Depressive Symptoms in Late Adulthood: A Cross-Sectional Analysis from a Large Cohort Study.

Bolzetta F, Veronese N, Stubbs B, Noale M, Vaona A, Demurtas J, Celotto S, Cacco C, Cester A, Caruso MG, Reddavide R, Notarnicola M, Maggi S, Koyanagi A, Fornaro M, Firth J, Smith L, Solmi M.

Nutrients. 2019 Apr 5;11(4). pii: E787. doi: 10.3390/nu11040787.

8.

Occult HBV infection may negatively impact on drug survival in patients with rheumatoid arthritis on treatment with a first biologic drug. An appraisal from the Biologic Apulian Registry (BIOPURE).

Carlino G, Fornaro M, Santo L, Bucci R, Semeraro A, Quarta L, D'Onofrio F, Marsico A, Zuccaro C, Falappone PC, Mazzotta D, Cantatore FP, Muratore M, Iannone F.

Reumatismo. 2019 Apr 1;71(1):24-30. doi: 10.4081/reumatismo.2019.1154.

9.

Alexithymia, Suicide Ideation and Homocysteine Levels in Drug Naïve Patients with Major Depression: A Study in the "Real World" Clinical Practice

De Berardis D, Olivieri L, Rapini G, Di Natale S, Serroni N, Fornaro M, Orsolini L, Valchera A, Carano A, Vellante F, Varasano PA, Lucidi Pressanti G, Serafini G, Pompili M, Martinotti G, Di Giannantonio M.

Clin Psychopharmacol Neurosci. 2019 May 31;17(2):318-322. doi: 10.9758/cpn.2019.17.2.318.

10.

Prevalence and correlates of major depressive disorder, bipolar disorder and schizophrenia among nursing home residents without dementia: systematic review and meta-analysis.

Fornaro M, Solmi M, Stubbs B, Veronese N, Monaco F, Novello S, Fusco A, Anastasia A, De Berardis D, Carvalho AF, de Bartolomeis A, Vieta E.

Br J Psychiatry. 2019 Mar 13:1-10. doi: 10.1192/bjp.2019.5. [Epub ahead of print]

PMID:
30864533
11.

Novel Pathways in the Treatment of Major Depression: Focus on the Glutamatergic System.

Tomasetti C, Montemitro C, Fiengo ALC, Santone C, Orsolini L, Valchera A, Carano A, Pompili M, Serafini G, Perna G, Vellante F, Martinotti G, Giannantonio MD, Kim YK, Nicola MD, Bellomo A, Ventriglio A, Fornaro M, Berardis DD.

Curr Pharm Des. 2019;25(4):381-387. doi: 10.2174/1381612825666190312102444.

PMID:
30864501
12.

Network analysis of the relationship between depressive symptoms, demographics, nutrition, quality of life and medical condition factors in the Osteoarthritis Initiative database cohort of elderly North-American adults with or at risk for osteoarthritis - CORRIGENDUM.

Solmi M, Koyanagi A, Thompson T, Fornaro M, Correll CU, Veronese N.

Epidemiol Psychiatr Sci. 2019 Mar 8:1. doi: 10.1017/S2045796019000064. [Epub ahead of print] No abstract available.

PMID:
30846023
13.
14.

A Bayesian mixed treatment comparison of efficacy of biologics and small molecules in early rheumatoid arthritis.

Venerito V, Lopalco G, Cacciapaglia F, Fornaro M, Iannone F.

Clin Rheumatol. 2019 May;38(5):1309-1317. doi: 10.1007/s10067-018-04406-z. Epub 2019 Jan 10. Review.

PMID:
30628014
15.

Reply to Dr. Gentili' "Analysis of tolerance to antidepressant drugs in FDA Adverse Event Reporting System".

Fornaro M.

Pharmacol Res. 2019 Mar;141:618. doi: 10.1016/j.phrs.2018.12.012. Epub 2018 Dec 15. No abstract available.

PMID:
30562570
16.

Choosing the appropriate pharmacotherapy for obsessive-compulsive disorder in adult patients with comorbid anxiety disorders: clinical and nosological considerations.

Fornaro M.

Expert Opin Pharmacother. 2019 Feb;20(2):123-126. doi: 10.1080/14656566.2018.1549225. Epub 2018 Nov 29. No abstract available.

PMID:
30496694
17.

Reply to Dr. Sharma' "Understanding antidepressant tachyphylaxis".

Fornaro M.

Pharmacol Res. 2019 Mar;141:620. doi: 10.1016/j.phrs.2018.11.025. Epub 2018 Nov 22. No abstract available.

PMID:
30471407
18.

Clozapine-related Sudden Pericarditis in a Patient Taking Long Acting Aripiprazole and Valproate: A Case Report.

De Berardis D, Fornaro M, Orsolini L, Olivieri L, Nappi F, Rapini G, Vellante F, Napoletano C, Serroni N, Giannantonio MD.

Clin Psychopharmacol Neurosci. 2018 Nov 30;16(4):505-507. doi: 10.9758/cpn.2018.16.4.505.

19.

Systematic review and exploratory meta-analysis of the efficacy, safety, and biological effects of psychostimulants and atomoxetine in patients with schizophrenia or schizoaffective disorder.

Solmi M, Fornaro M, Toyoshima K, Carvalho AF, Köhler CA, Veronese N, Stubbs B, de Bartolomeis A, Correll CU.

CNS Spectr. 2018 Nov 21:1-17. doi: 10.1017/S1092852918001050. [Epub ahead of print]

PMID:
30460884
20.

Lipids and Atherogenic Indices Fluctuation in Rheumatoid Arthritis Patients on Long-Term Tocilizumab Treatment.

Cacciapaglia F, Anelli MG, Rinaldi A, Fornaro M, Lopalco G, Scioscia C, Lapadula G, Iannone F.

Mediators Inflamm. 2018 Oct 14;2018:2453265. doi: 10.1155/2018/2453265. eCollection 2018.

21.

The emergence of loss of efficacy during antidepressant drug treatment for major depressive disorder: An integrative review of evidence, mechanisms, and clinical implications.

Fornaro M, Anastasia A, Novello S, Fusco A, Pariano R, De Berardis D, Solmi M, Veronese N, Stubbs B, Vieta E, Berk M, de Bartolomeis A, Carvalho AF.

Pharmacol Res. 2019 Jan;139:494-502. doi: 10.1016/j.phrs.2018.10.025. Epub 2018 Oct 29. Review.

PMID:
30385364
22.

Safety, tolerability, and preliminary efficacy of an IGF-1 mimetic in patients with spinal and bulbar muscular atrophy: a randomised, placebo-controlled trial.

Grunseich C, Miller R, Swan T, Glass DJ, El Mouelhi M, Fornaro M, Petricoul O, Vostiar I, Roubenoff R, Meriggioli MN, Kokkinis A, Guber RD, Budron MS, Vissing J, Soraru G, Mozaffar T, Ludolph A, Kissel JT, Fischbeck KH; BVS857 study group.

Lancet Neurol. 2018 Dec;17(12):1043-1052. doi: 10.1016/S1474-4422(18)30320-X. Epub 2018 Oct 15.

PMID:
30337273
23.

Eradicating Suicide at Its Roots: Preclinical Bases and Clinical Evidence of the Efficacy of Ketamine in the Treatment of Suicidal Behaviors.

De Berardis D, Fornaro M, Valchera A, Cavuto M, Perna G, Di Nicola M, Serafini G, Carano A, Pompili M, Vellante F, Orsolini L, Fiengo A, Ventriglio A, Yong-Ku K, Martinotti G, Di Giannantonio M, Tomasetti C.

Int J Mol Sci. 2018 Sep 23;19(10). pii: E2888. doi: 10.3390/ijms19102888. Review.

24.

Paediatric Home Artificial Nutrition in Italy: Report from 2016 Survey on Behalf of Artificial Nutrition Network of Italian Society for Gastroenterology, Hepatology and Nutrition (SIGENP).

Lezo A, Capriati T, Spagnuolo MI, Lacitignola L, Goreva I, Di Leo G, Cecchi N, Gandullia P, Amarri S, Forchielli ML, Dipasquale V, Parma B, Gatti S, Ravaioli E, Salvatore S, Mainetti M, Norsa L, Pellegrino M, Fornaro M, Fiorito V, Lanari M, Giaquinto E, Verduci E, Baldassarre ME, Diamanti A.

Nutrients. 2018 Sep 16;10(9). pii: E1311. doi: 10.3390/nu10091311.

25.

The identification of biomarkers predicting acute and maintenance lithium treatment response in bipolar disorder: A plea for further research attention.

Fornaro M, De Berardis D, Anastasia A, Novello S, Fusco A, Cattaneo CI, Solmi M, Monaco F, Veronese N, Kim YK, de Bartolomeis A.

Psychiatry Res. 2018 Nov;269:658-672. doi: 10.1016/j.psychres.2018.08.034. Epub 2018 Aug 16. Review.

PMID:
30216918
26.

Pharmacological management of depression in patients with multiple sclerosis.

Carta MG, Paribello P, Anastasia A, De Berardis D, Nardi AE, Fornaro M.

Expert Opin Pharmacother. 2018 Oct;19(14):1533-1540. doi: 10.1080/14656566.2018.1516207. Epub 2018 Sep 12. Review.

PMID:
30207800
27.

Evaluation of a few discrete clinical markers may predict categorization of actively symptomatic non-acute schizophrenia patients as treatment resistant or responders: A study by ROC curve analysis and multivariate analyses.

Iasevoli F, Avagliano C, Altavilla B, Barone A, Ciccarelli M, D'Ambrosio L, Notar Francesco D, Razzino E, Fornaro M, de Bartolomeis A.

Psychiatry Res. 2018 Nov;269:481-493. doi: 10.1016/j.psychres.2018.08.109. Epub 2018 Aug 31.

PMID:
30195742
28.

Influence of baseline modified Rheumatic Disease Comorbidity Index (mRDCI) on drug survival and effectiveness of biological treatment in patients affected with Rheumatoid arthritis, Spondyloarthritis and Psoriatic arthritis in real-world settings.

Iannone F, Salaffi F, Fornaro M, Di Carlo M, Gentileschi S, Cantarini L, Lopalco G.

Eur J Clin Invest. 2018 Nov;48(11):e13013. doi: 10.1111/eci.13013. Epub 2018 Aug 23.

PMID:
30079593
29.

Safety of antipsychotics for the treatment of schizophrenia: a focus on the adverse effects of clozapine.

De Berardis D, Rapini G, Olivieri L, Di Nicola D, Tomasetti C, Valchera A, Fornaro M, Di Fabio F, Perna G, Di Nicola M, Serafini G, Carano A, Pompili M, Vellante F, Orsolini L, Martinotti G, Di Giannantonio M.

Ther Adv Drug Saf. 2018 May;9(5):237-256. doi: 10.1177/2042098618756261. Epub 2018 Feb 6. Review.

30.

The relationship between the dietary inflammatory index (DII®) and incident depressive symptoms: A longitudinal cohort study.

Shivappa N, Hébert JR, Veronese N, Caruso MG, Notarnicola M, Maggi S, Stubbs B, Firth J, Fornaro M, Solmi M.

J Affect Disord. 2018 Aug 1;235:39-44. doi: 10.1016/j.jad.2018.04.014. Epub 2018 Apr 4.

PMID:
29649709
31.

Comparison of familial and non-familial suicidal behaviors among people with major depressive disorder: Testing the discriminative predicting role of high-yield clinical variables.

Fornaro M, Grunebaum MF, Burke AK, Mann JJ, Oquendo MA.

J Psychiatr Res. 2018 Jul;102:118-122. doi: 10.1016/j.jpsychires.2018.02.021. Epub 2018 Feb 23.

PMID:
29635115
32.

Differentiating between bipolar and unipolar depression in functional and structural MRI studies.

Han KM, De Berardis D, Fornaro M, Kim YK.

Prog Neuropsychopharmacol Biol Psychiatry. 2019 Apr 20;91:20-27. doi: 10.1016/j.pnpbp.2018.03.022. Epub 2018 Mar 28. Review.

PMID:
29601896
33.
34.

Clinical and psychopathological features associated with treatment-emergent mania in bipolar-II depressed outpatients exposed to antidepressants.

Fornaro M, Anastasia A, Monaco F, Novello S, Fusco A, Iasevoli F, De Berardis D, Veronese N, Solmi M, de Bartolomeis A.

J Affect Disord. 2018 Jul;234:131-138. doi: 10.1016/j.jad.2018.02.085. Epub 2018 Mar 1.

PMID:
29525354
35.

Tough Composite Hydrogels with High Loading and Local Release of Biological Drugs.

Li J, Weber E, Guth-Gundel S, Schuleit M, Kuttler A, Halleux C, Accart N, Doelemeyer A, Basler A, Tigani B, Wuersch K, Fornaro M, Kneissel M, Stafford A, Freedman BR, Mooney DJ.

Adv Healthc Mater. 2018 May;7(9):e1701393. doi: 10.1002/adhm.201701393. Epub 2018 Feb 14.

36.

Incidence, prevalence and clinical correlates of antidepressant-emergent mania in bipolar depression: a systematic review and meta-analysis.

Fornaro M, Anastasia A, Novello S, Fusco A, Solmi M, Monaco F, Veronese N, De Berardis D, de Bartolomeis A.

Bipolar Disord. 2018 May;20(3):195-227. doi: 10.1111/bdi.12612. Epub 2018 Feb 14.

PMID:
29441650
37.

Protein-C Reactive as Biomarker Predictor of Schizophrenia Phases of Illness? A Systematic Review.

Orsolini L, Sarchione F, Vellante F, Fornaro M, Matarazzo I, Martinotti G, Valchera A, Di Nicola M, Carano A, Di Giannantonio M, Perna G, Olivieri L, De Berardis D.

Curr Neuropharmacol. 2018;16(5):583-606. doi: 10.2174/1570159X16666180119144538. Review.

38.

Progress in bipolar disorder drug design toward the development of novel therapeutic targets: a clinician's perspective.

Fornaro M, Kardash L, Novello S, Fusco A, Anastasia A, De Berardis D, Perna G, Carta MG.

Expert Opin Drug Discov. 2018 Mar;13(3):221-228. doi: 10.1080/17460441.2018.1428554. Epub 2018 Jan 22. Review.

PMID:
29357703
39.

A bibliometric analysis of scientific production on atypical antipsychotic drugs from Italy

López-Muñoz F, De Berardis D, Fornaro M, Vellante F, di Giannantonio M, Povedano-Montero FJ, Póveda Fernández-Martín M, Rubio G, Álamo C.

Riv Psichiatr. 2017 Nov-Dec;52(6):236-246. doi: 10.1708/2846.28727.

PMID:
29343873
40.

Predictors of hospitalization length of stay among re-admitted treatment-resistant Bipolar Disorder inpatients.

Fornaro M, Iasevoli F, Novello S, Fusco A, Anastasia A, De Berardis D, Valchera A, de Bartolomeis A.

J Affect Disord. 2018 Mar 1;228:118-124. doi: 10.1016/j.jad.2017.12.009. Epub 2017 Dec 7.

PMID:
29245092
41.

ATP Citrate Lyase Regulates Myofiber Differentiation and Increases Regeneration by Altering Histone Acetylation.

Das S, Morvan F, Morozzi G, Jourde B, Minetti GC, Kahle P, Rivet H, Brebbia P, Toussaint G, Glass DJ, Fornaro M.

Cell Rep. 2017 Dec 12;21(11):3003-3011. doi: 10.1016/j.celrep.2017.11.038.

42.

Prevalence of Catatonia and Its Moderators in Clinical Samples: Results from a Meta-analysis and Meta-regression Analysis.

Solmi M, Pigato GG, Roiter B, Guaglianone A, Martini L, Fornaro M, Monaco F, Carvalho AF, Stubbs B, Veronese N, Correll CU.

Schizophr Bull. 2018 Aug 20;44(5):1133-1150. doi: 10.1093/schbul/sbx157. Review.

PMID:
29140521
43.

The efficacy and tolerability of paliperidone in mania of bipolar disorder: A preliminary meta-analysis.

Chang HY, Tseng PT, Stubbs B, Chu CS, Li DJ, Fornaro M, Carvalho A, Solmi M, Veronese N, Vieta E, Chen TY, Chen YW, Lin PY, Chow PC.

Exp Clin Psychopharmacol. 2017 Oct;25(5):422-433. doi: 10.1037/pha0000148. Review.

PMID:
29048190
44.

Sudden valproate-induced hyperammonemia managed with L-carnitine in a medically healthy bipolar patient: Essential review of the literature and case report.

Cattaneo CI, Ressico F, Valsesia R, D'Innella P, Ballabio M, Fornaro M.

Medicine (Baltimore). 2017 Sep;96(39):e8117. doi: 10.1097/MD.0000000000008117. Review.

45.

Alexithymia and Suicide Risk in Psychiatric Disorders: A Mini-Review.

De Berardis D, Fornaro M, Orsolini L, Valchera A, Carano A, Vellante F, Perna G, Serafini G, Gonda X, Pompili M, Martinotti G, Di Giannantonio M.

Front Psychiatry. 2017 Aug 14;8:148. doi: 10.3389/fpsyt.2017.00148. eCollection 2017. Review.

46.

Aspirin and incident depressive symptoms: A longitudinal cohort study over 8 years.

Veronese N, Koyanagi A, Stubbs B, Solmi M, Fornaro M, Fernandes BS, Mueller C, Thompson T, Carvalho AF, Maggi S.

Int J Geriatr Psychiatry. 2018 Feb;33(2):e193-e198. doi: 10.1002/gps.4767. Epub 2017 Aug 6. Erratum in: Int J Geriatr Psychiatry. 2018 May;33(5):802.

47.

Safety, tolerability, and risks associated with first- and second-generation antipsychotics: a state-of-the-art clinical review.

Solmi M, Murru A, Pacchiarotti I, Undurraga J, Veronese N, Fornaro M, Stubbs B, Monaco F, Vieta E, Seeman MV, Correll CU, Carvalho AF.

Ther Clin Risk Manag. 2017 Jun 29;13:757-777. doi: 10.2147/TCRM.S117321. eCollection 2017. Review.

48.

Creativity and psychiatric illness: A functional perspective beyond chaos.

Vellante F, Sarchione F, Ebisch SJH, Salone A, Orsolini L, Marini S, Valchera A, Fornaro M, Carano A, Iasevoli F, Martinotti G, De Berardis D, Di Giannantonio M.

Prog Neuropsychopharmacol Biol Psychiatry. 2018 Jan 3;80(Pt B):91-100. doi: 10.1016/j.pnpbp.2017.06.038. Epub 2017 Jul 5. Review. No abstract available.

PMID:
28689007
49.

The burden of mood-disorder/cerebrovascular disease comorbidity: essential neurobiology, psychopharmacology, and physical activity interventions.

Fornaro M, Solmi M, Veronese N, De Berardis D, Buonaguro EF, Tomasetti C, Perna G, Preti A, Carta MG.

Int Rev Psychiatry. 2017 Oct;29(5):425-435. doi: 10.1080/09540261.2017.1299695. Epub 2017 Jul 6. Review.

PMID:
28681620
50.

Efficacy, safety and tolerability of aripiprazole in bipolar disorder: An updated systematic review and meta-analysis of randomized controlled trials.

Li DJ, Tseng PT, Stubbs B, Chu CS, Chang HY, Vieta E, Fornaro M, Carvalho AF, Solmi M, Veronese N, Chen TY, Chen YW, Lin PY, Chow PC.

Prog Neuropsychopharmacol Biol Psychiatry. 2017 Oct 3;79(Pt B):289-301. doi: 10.1016/j.pnpbp.2017.06.023. Epub 2017 Jun 23. Review.

PMID:
28651936

Supplemental Content

Loading ...
Support Center